MARKET

DNA

DNA

Ginkgo Bioworks Holdings Inc
NYSE
1.940
+0.190
+10.86%
After Hours: 1.970 +0.03 +1.55% 19:45 01/27 EST
OPEN
1.740
PREV CLOSE
1.750
HIGH
1.980
LOW
1.720
VOLUME
20.64M
TURNOVER
0
52 WEEK HIGH
6.38
52 WEEK LOW
1.450
MARKET CAP
3.76B
P/E (TTM)
-0.8682
1D
5D
1M
3M
1Y
5Y
BRIEF-Ginkgo Bioworks Holdings Inc Files For Offering Of Up To 7.3 Million Class A Common Stock By Selling Securityholders
Reuters · 2d ago
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2022 Update
Seeking Alpha · 2d ago
Cathie Wood Gets Back on Track; Here Are 2 Stocks She’s Snapping Up
TipRanks · 4d ago
Insider Sell: Ginkgo Bioworks Holdings
Insider Sell: Ginkgo Bioworks Holdings
MT Newswires · 5d ago
Ginkgo, Namuh team up to develop infant formula products
Seeking Alpha · 01/18 12:47
Ginkgo Bioworks, NAMUH to Collaborate for Infant Nutrition Products
Ginkgo Bioworks, NAMUH to Collaborate for Infant Nutrition Products
MT Newswires · 01/18 08:00
Ginkgo Bioworks And The Public Health Center Of The Ukraine Ministry Of Health Announce Collaboration To Implement Biosecurity Capabilities In Ukraine
Benzinga · 01/17 13:14
Ginkgo Bioworks and Xwell add flu viruses to genomic surveillance program
Seeking Alpha · 01/17 13:08
More
About DNA
Ginkgo Bioworks Holdings, Inc. is engaged in building the horizontal platform for cell programming. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company operates through two segments: Foundry and Biosecurity. Foundry consists of research and development services performed under collaboration and license agreements relating to the Company’s cell programming platform. Its cell programming platform includes two assets: the Foundry, biology lab facilities, enabled by investment in workflows, custom software, robotic automation, and data science and analytics, which is paired with the Company’s Codebase, a collection of biological parts and a database of biological data used to program cells. Biosecurity consists of COVID-19 testing products and services primarily provided to public health authorities.

Webull offers kinds of Ginkgo Bioworks Holdings Inc stock information, including NYSE:DNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DNA stock methods without spending real money on the virtual paper trading platform.